Published in Medical Letter on the CDC and FDA, November 23rd, 2008
Ms. Wang, who joins the firm after serving as the head of AstraZeneca's legal departments in Asia Pacific and China, will focus her practice on corporate, commercial and regulatory aspects of life sciences matters. At AstraZeneca, Ms. Wang advised on critical strategic and operational initiatives to ensure statutory compliance and realization of business objectives.
"Katherine has had an extraordinary legal career and has been at the forefront of legal developments in Asia in the life...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.